Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Capillary Blood Collection Devices Market Size & Growth Forecast 2027–2036, By Segments (Material, Product Type, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 4254| Published Date: Jul-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Capillary Blood Collection Devices Market size stood at USD 2.18 Billion in 2026 and is predicted to grow at 8.16% CAGR from 2027 to 2036, reaching USD 4.78 Billion by 2036. The industry revenue for 2027 is calculated at USD 2.33 Billion.

Base Year Value (2025)
USD 2.06 Billion
CAGR (2026-2035)
7.8%
Forecast Year Value (2035)
USD 4.37 Billion
Historical Data Period
2021-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Capillary Blood Collection Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America led in 2026 due to advanced healthcare infrastructure, established diagnostic networks, widespread testing, and growing demand for decentralized and home-based sampling.
  • Growth is supported by expanding healthcare access, rising diagnostic demand, infrastructure improvements, decentralized testing, and increasing need for convenient sampling across emerging economies.

Segment Momentum

  • Plastic accounted for 62.96% of the market in 2026 because it is lightweight, durable, breakage-resistant, and well suited for cost-effective disposable devices that support infection control and patient safety.
  • Lancing devices are the fastest-growing product type as ongoing improvements in safety, ergonomics, and ease of use support routine diagnostic testing and frequent blood monitoring in healthcare and home settings.

Market Expansion Drivers

  • Rising chronic disease prevalence driving frequent diagnostic testing requirements
  • Growing point-of-care testing adoption increasing demand for minimally invasive sampling
  • Expansion of home healthcare boosting self-collection diagnostic device utilization

Leading Market Participants

  • Prominent companies in the capillary blood collection devices market include Becton, Dickinson and Company (United States), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Terumo Corporation (Japan), Sarstedt AG & Co. KG (Germany), Cardinal Health, Inc. (United States), Greiner Bio-One International GmbH (Austria), Medtronic plc (Ireland), Danaher Corporation (United States)

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 2.18 Billion
  • 2027 Estimated Market Size: USD 2.33 Billion
  • Projected Market Size: USD 4.78 Billion by 2036
  • Growth Forecast: 8.16% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Plastic (Material) | Lancing Devices (Product Type) | Glucose Monitoring (Application) | Hospitals and Clinics (End-use)
  • Emerging Opportunity Segment: Plastic (Material) | Lancing Devices (Product Type) | Glucose Monitoring (Application) | Home Diagnosis (End-use)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising chronic disease prevalence driving frequent diagnostic testing requirements

The increasing burden of long-term health conditions is creating sustained demand for regular monitoring and diagnostic procedures. Rising chronic disease prevalence is driving the capillary blood collection devices market growth as patients and healthcare providers seek convenient sampling solutions for repeated testing with minimal discomfort. These devices support routine assessments in areas where frequent blood analysis is required, including disease monitoring and preventive healthcare programs.

Growing point-of-care testing adoption increasing demand for minimally invasive sampling

Healthcare systems are expanding decentralized diagnostic approaches that enable faster testing closer to patients rather than relying solely on centralized laboratories. Growing point-of-care testing adoption will accelerate the capillary blood collection devices market growth by increasing the need for compact, easy-to-use sampling tools that support rapid diagnostic workflows. Minimally invasive collection methods improve patient comfort and simplify testing procedures across clinics, emergency settings, and other care environments.

Expansion of home healthcare boosting self-collection diagnostic device utilization

The shift toward patient-centered care models is encouraging greater use of diagnostic solutions outside traditional healthcare facilities. Expansion of home healthcare will strengthen the capillary blood collection devices market growth by increasing demand for self-collection devices that allow individuals to perform monitoring procedures conveniently at home. These solutions support remote healthcare programs by enabling easier sample collection while reducing the frequency of in-person visits for routine testing.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising chronic disease prevalence driving frequent diagnostic testing requirements 2% High North America, Europe High Near Term
Growing point-of-care testing adoption increasing demand for minimally invasive sampling 1.8% High North America, Asia Pacific High Near Term
Expansion of home healthcare boosting self-collection diagnostic device utilization 1.5% Moderate Europe, North America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
Largest Market Share in 2026

North America (Largest Region)

North America led the capillary blood collection devices market in 2026, benefiting from advanced healthcare infrastructure, widespread diagnostic testing, and increasing demand for convenient blood sampling methods. The region's established laboratory and point-of-care testing networks support the adoption of devices designed to simplify sample collection while reducing the complexity associated with conventional blood-drawing procedures. Growing emphasis on decentralized diagnostics, home-based healthcare, and efficient testing workflows is also encouraging the use of capillary sampling technologies across healthcare settings.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is expected to experience the fastest growth, supported by expanding healthcare access, rising demand for diagnostic testing, and improvements in medical infrastructure. Increasing healthcare expenditure and the development of decentralized and point-of-care diagnostic services are creating greater opportunities for capillary blood collection devices. The growing prevalence of chronic and infectious conditions is also strengthening the need for accessible testing, while healthcare modernization and wider availability of diagnostic facilities across emerging economies are supporting greater adoption of convenient blood collection technologies.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Point-of-Care Adoption

The U.S. market is expanding the use of capillary blood collection devices across point-of-care testing, home diagnostics, and outpatient settings. Manufacturers serving the U.S. emphasize user-friendly designs that improve sample quality and patient convenience.

Germany 🇩🇪

Laboratory Workflow Support

Germany prioritizes capillary blood collection devices that deliver consistent sample quality while supporting efficient laboratory and clinical workflows. Healthcare providers in Germany value products that enhance reliability, safety, and ease of use during routine testing.

Japan 🇯🇵

Patient Comfort Innovation

Japan focuses on capillary blood collection devices designed to minimize discomfort while maintaining dependable sample collection. Manufacturers in Japan continue refining ergonomic designs and safety features for routine diagnostic applications.

South Korea 🇰🇷

Diagnostic Accessibility

South Korea is expanding the use of capillary blood collection devices in decentralized healthcare and preventive testing environments. Device suppliers in South Korea emphasize convenient, safety-oriented solutions that support efficient specimen collection across diverse care settings.

France 🇫🇷

Preventive Testing Support

France encourages wider use of capillary blood collection devices in preventive care and routine diagnostic services. Healthcare providers in France increasingly seek devices that combine patient safety with consistent collection performance in outpatient environments.

Italy 🇮🇹

Routine Care Optimization

Italy emphasizes practical capillary blood collection devices that improve efficiency during routine diagnostic procedures in hospitals and clinics. Manufacturers serving Italy focus on dependable products that simplify specimen collection while supporting consistent clinical performance.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Capillary Blood Collection Devices Market Share (%), Material, 2025

Plastic
Glass
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Material Segment Analysis: Plastic (Largest & Fastest-Growing Segment)

Holding the largest share of the capillary blood collection devices market, the plastic segment accounted for 62.96% in 2026 while also emerging as the fastest-growing material segment. Its widespread adoption is driven by its lightweight nature, durability, and resistance to breakage, making it highly suitable for routine blood collection procedures across hospitals, diagnostic laboratories, and point-of-care settings. Plastic materials also support cost-effective manufacturing and compatibility with disposable device designs, helping reduce contamination risks and improve patient safety. Continued emphasis on efficient sample collection and infection control practices is expected to sustain the segment’s strong market position and growth momentum.

Product Type Segment Analysis: Lancing Devices (Largest & Fastest-Growing Segment)

The lancing devices segment led the product type category in 2026 and also remained the fastest-growing segment. These devices play a critical role in obtaining capillary blood samples quickly and with minimal discomfort, making them indispensable for routine diagnostic testing. Continuous product improvements, including enhanced safety mechanisms, ergonomic designs, and greater ease of use, have encouraged broader adoption in both healthcare facilities and home care environments. Rising demand for frequent blood testing, particularly for chronic disease management, continues to reinforce the segment’s long-term expansion.

Application Segment Analysis: Glucose Monitoring (Largest &Fastest-Growing Segment)

The glucose monitoring segment dominated the capillary blood collection devices market in 2026 while also representing the fastest-growing application. Increasing prevalence of diabetes and the growing importance of regular blood glucose monitoring have significantly strengthened demand for reliable capillary blood collection solutions. Expanding adoption of home-based healthcare, coupled with improvements in portable diagnostic technologies, has further accelerated the use of these devices. Ongoing focus on early disease detection and continuous patient monitoring is expected to maintain the segment’s leading position.

Segment Sub-Segment Largest Segment Fastest Growing
Material Plastic, Glass, Others Plastic Plastic
Product Type Micro-container Tubes, Micro-hematocrit Tubes, Warming Devices, Lancing Devices, Others Lancing Devices Lancing Devices
Application Glucose Monitoring, Hematocrit Testing, Cholesterol Testing, Coagulation Testing, Others Glucose Monitoring Glucose Monitoring
End-use Hospitals and Clinics, Blood Banks, Diagnostic Centers, Home Diagnosis, Others Hospitals and Clinics Home Diagnosis
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the capillary blood collection devices market:

  1. Becton Dickinson and Company (United States)
  2. Abbott Laboratories (United States)
  3. F. Hoffmann-La Roche Ltd (Switzerland)
  4. Siemens Healthineers AG (Germany)
  5. Terumo Corporation (Japan)
  6. Sarstedt AG & Co. KG (Germany)
  7. Cardinal Health, Inc. (United States)
  8. Greiner Bio-One International GmbH (Austria)
  9. Medtronic plc (Ireland)
  10. Danaher Corporation (United States)

Clinical workflow efficiency and patient-centered diagnostics are reshaping competitive dynamics in the capillary blood collection devices market, prompting manufacturers to prioritize ease of use, sample integrity, and compatibility with decentralized testing environments. Suppliers are expanding beyond conventional device offerings by incorporating ergonomic designs, safety-focused collection mechanisms, and solutions that support reliable specimen handling across hospitals, diagnostic laboratories, and home-based care settings. Competitive positioning increasingly depends on the ability to satisfy evolving clinical standards while addressing the growing demand for minimally invasive sampling, encouraging sustained investment in product refinement and application-specific innovation.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
RedDrop, Inc. Feb-26 RedDrop, Inc. completed an IRB-approved, parent-administered home-use study of its RedDrop ONE capillary blood collection device involving 50 pediatric participants. The trial validated reliable sample collection, overnight shipment, and laboratory processing, proving the system's operational viability for decentralized pediatric diagnostics and remote patient monitoring workflows.
Becton, Dickinson and Company Dec-23 Becton, Dickinson and Company secured FDA 510(k) clearances for its BD MiniDraw Collection System. The device enables low-volume capillary blood collection via fingersticks for lipid panels, selected chemistry tests, and hemoglobin/hematocrit testing, bringing lab-quality results to decentralized settings and expanding the company's diagnostic testing portfolio.
Becton, Dickinson and Company Feb-20 Becton, Dickinson and Company entered into a long-term strategic partnership with Babson Diagnostics to deploy laboratory-quality, small-volume capillary blood collection services across retail pharmacies. The collaboration optimizes diagnostic testing distribution by shifting sample collection to convenient, customer-friendly retail healthcare environments.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Capillary Blood Collection Devices Market — Custom Segments

Segment Sub-Segment
No segment data available.

Capillary Blood Collection Devices Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How much revenue does the capillary blood collection devices market generate?

The market valuation of the capillary blood collection devices is USD 2.33 Billion in 2027.

What is the projected value of the capillary blood collection devices industry by 2035?

Capillary Blood Collection Devices Market size stood at USD 2.18 Billion in 2026 and is predicted to grow at 8.16% CAGR from 2027 to 2036, reaching USD 4.78 Billion by 2036.

How is point-of-care testing influencing demand for capillary blood collection devices?

Expanding point-of-care testing is increasing demand for compact, minimally invasive sampling tools that support rapid diagnostic workflows. These devices improve patient comfort while enabling efficient testing across clinics, emergency settings, and decentralized care environments.

Why is home healthcare accelerating adoption of capillary blood collection devices?

The shift toward home-based care is increasing demand for self-collection devices that simplify routine monitoring. These solutions support remote healthcare programs by enabling convenient sample collection while reducing the need for frequent in-person visits.

Why is plastic the leading material in the capillary blood collection devices market?

Plastic accounted for 62.96% of the market in 2026 because it is lightweight, durable, breakage-resistant, and well suited for cost-effective disposable devices that support infection control and patient safety.

Which product type is growing fastest in the capillary blood collection devices market?

Lancing devices are the fastest-growing product type as ongoing improvements in safety, ergonomics, and ease of use support routine diagnostic testing and frequent blood monitoring in healthcare and home settings.

What supports North America's leadership in capillary blood collection devices?

North America led in 2026 due to advanced healthcare infrastructure, established diagnostic networks, widespread testing, and growing demand for decentralized and home-based sampling.

Why is Asia Pacific expected to see faster growth in capillary blood collection devices?

Growth is supported by expanding healthcare access, rising diagnostic demand, infrastructure improvements, decentralized testing, and increasing need for convenient sampling across emerging economies.

What are the prominent companies operating in the capillary blood collection devices landscape?

Prominent companies in the capillary blood collection devices market include Becton, Dickinson and Company (United States), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Terumo Corporation (Japan), Sarstedt AG & Co. KG (Germany), Cardinal Health, Inc. (United States), Greiner Bio-One International GmbH (Austria), Medtronic plc (Ireland), Danaher Corporation (United States)
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →